The global Spinal Muscular Atrophy (SMA) treatment market is projected to grow at a considerable CAGR of more than 10% during the forecast period (2019-2025). The high incidence of the spinal muscular atrophy and the growing awareness among people related to its diagnosis and treatment are the key factors to drive the growth of the global SMA treatment market. According to the National Organization of Spinal Muscular Atrophy, the incidence of SMA is 1 in 6,000 to 1 in 10,000 live births with a carrier frequency of 1/40-1/60. SMA is a group of inherited diseases that affects the functioning of muscles due to deterioration that result in weakness and may cause death of the patients. The increasing in research R&D activities related to the development of therapies and treatment options by the major market players is anticipated to fuel the market during the forecast period.
Get Free Sample Copy @ https://www.omrglobal.com/request-sample/spinal-muscular-atrophy-sma-treatment-market
The considerable number of several drugs in pipeline for advanced stages of clinical trials by some of the key pharmaceutical companies will accelerate the demand of the spinal muscular atrophy treatment market. For instance, in November 2019, F. Hoffman La Roche’s pipeline candidate of Risdiplam, which recently received a review from the FDA and is anticipated to receive FDA approval by end of May 2020. Furthermore, the growing number of initiatives related to the pre-diagnosis and positive reimbursement policies is again fuelling the market growth. The high cost of treatment of SMA is a major factor that may restrain its market growth. However, the growing awareness related to treatment of this disease to create new opportunities for the market growth during the forecast period.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/spinal-muscular-atrophy-sma-treatment-market
Market Segmentation
• Global SMA Treatment Market by Treatment Type
• Gene Therapy
• Medication
• Global SMA Treatment Market by Disease Type
• Type l
• Type ll
• Type lll
• Type lV
Regional Analysis
• North America
• US
• Canada
• Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
• Asia-Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
• Rest of the World
Company Profiles
• Astellas Pharma Inc.
• Biogen, Inc.
• Cytokinetics, Inc.
• F. Hoffmann-La Roche AG
• Genetec, Inc.
• Ionis Pharmaceuticals, Inc.
• Novartis AG (Avexis Inc.)
• Pfizer, Inc.
• PTC Therapeutics Inc.
• Regeneron Pharmaceuticals, Inc.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/spinal-muscular-atrophy-sma-treatment-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404